ClinicalTrials.gg
Status unknownNCT04913623Updated Jun 4, 2021

Correlation of Intramedullary Pressure and Systemic Inflammatory Parameters in Cemented Femoral Stem

An observational study in Arthroplasty Complications, sponsored by University Clinical Centre of Kosova. Status unknown at 1 site in Kosovo. Per ClinicalTrials.gov, last updated 2021-06-04.

Sponsored by University Clinical Centre of Kosova · Observational

The sponsor has not verified this record recently (last verified May 2021), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
60
Sex
All
01

Study summary

The cemented femoral stem have impact on increase on systemic parameters.

Evaluation of the level of histamine, C-reactive protein (CRP) and leukocytes formula, IL1b, TNF alpha, IL6 and the reflection of changes of these parameters in the intra-operative course of hip replacement.

Read the detailed description

Implantation of total endoprosthesis is a very common surgical procedure and is performed with and without bone cement.

In most cases during cementation of the femoral component there are changes in blood pressure, SpO2, heartbeat and other vital parameters which can cause complications during surgery.

Comparing the system parameters between the two groups and deriving these results will help the medical staff to be more professionally prepared to resolve possible complications.

02

Conditions studied

  • Arthroplasty Complications
03

In context

Lead sponsor

University Clinical Centre of Kosova is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients are from the waiting list for surgery. All are included in the study with their consent The femoral component cemented or non-cemented is realized based on bone quality, age and its testing during surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

The inclusion criteria were as follows:

  • All patients willing to participate who underwent cemented and uncemented THA,
  • With no limit on age

Exclusion criteria

Exclusion Criteria:

The exclusion criteria were patients with:

  • Periprosthetic fractures,
  • Pathological fractures
  • THA revision
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
60 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Correlation of intramedullary pressure and systemic inflammatory parameters in cemented THA

    Procedure: Hip Replacement

  • Correlation of intramedullary pressure and systemic inflammatory parameters in non cemented THA

    Procedure: Hip Replacement

Interventions

  • ProcedureHip Replacement

    The hip replacement surgery is when a damaged hip is replaced with artificial one

    Also known as: Hip replacement surgery, Arthroplasty

06

What researchers measure

Primary outcomes

  1. Change of systemic parameters during and after hip replacement (Histamine)

    Analysis of the impact of cement in different laboratory parameters such as histamine

    Time frame: The measurement of these laboratory parameters 5 minutes before and 10 minutes after surgical procedures will reflect the impact of cements in the eventual post-surgical complications, such are embolism and other complications.

  2. Change of systemic parameters during and after hip replacement (CRP)

    Analysis of the impact of cement in different laboratory parameters such as C-reactive protein (CRP)

    Time frame: The measurement of these laboratory parameters 5 minutes before and 10 minutes after surgical procedures will reflect the impact of cements in the eventual post-surgical complications, such are embolism and other complications.

  3. Change of systemic parameters during and after hip replacement (Leukocytes formula)

    Analysis of the impact of cement in different laboratory parameters such as changes of leukocytes formula

    Time frame: The measurement of these laboratory parameters 5 minutes before and 10 minutes after surgical procedures will reflect the impact of cements in the eventual post-surgical complications, such are embolism and other complications.

  4. Change of systemic parameters during and after hip replacement (IL1b)

    Analysis of the impact of cement in different laboratory parameters such as IL1b

    Time frame: The measurement of these laboratory parameters 5 minutes before and 10 minutes after surgical procedures will reflect the impact of cements in the eventual post-surgical complications, such are embolism and other complications.

  5. Change of systemic parameters during and after hip replacement (TNF alpha)

    Analysis of the impact of cement in different laboratory parameters such are TNF alpha

    Time frame: The measurement of these laboratory parameters 5 minutes before and 10 minutes after surgical procedures will reflect the impact of cements in the eventual post-surgical complications, such are embolism and other complications.

  6. Change of systemic parameters during and after hip replacement (IL6)

    Analysis of the impact of cement in different laboratory parameters such as IL6.

    Time frame: The measurement of these laboratory parameters 5 minutes before and 10 minutes after surgical procedures will reflect the impact of cements in the eventual post-surgical complications, such are embolism and other complications.

Secondary outcomes

  1. Difference of arterial pressure

    Difference of arterial pressure after implantation of femoral component

    Time frame: The changes will be measured 5 minutes before implantation and during first 10 minutes after implantation

  2. Difference of changes of Leukocyte formula

    Difference of changes of Leukocyte formula after implantation of femoral component

    Time frame: The blood will be taken from patience 1 hour before and Post Operative Day One

  3. Difference of SpO2

    Difference of SpO2 after implantation of femoral component The changes will be measured by the device monitor connected to patient

    Time frame: The changes will be measured 5 minutes before implantation and during first 10 minutes after implantation]

07

Study locations

1 of 1 sites recruiting
  • University Clinical Center of Kosovo
    Prishtina, 10000, Kosovo
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2021 to primary completion in May 2021, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 5, 2021
First posted
Jun 4, 2021
StartActual
Mar 23, 2021
Primary completionActual
May 23, 2021
CompletionEst.
Jun 23, 2021
Last update
Jun 4, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 4, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04913623
Lead sponsor
University Clinical Centre of Kosova
Responsible party
Skender Ukaj (Specialist of Orthopaedics and Trauma, University Clinical Centre of Kosova) — Principal investigator
First posted
Jun 4, 2021
Start date
Mar 23, 2021
Primary completion
May 23, 2021
Completion
Jun 23, 2021 (estimated)
Last update
Jun 4, 2021

Study contacts

Skender Ukaj, MD
Contact
skender.ukaj@uni-gjk.org
0038344603609

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion